|
1
|
Applegate CC and Lane MA: Role of
retinoids in the prevention and treatment of colorectal cancer.
World J Gastrointest Oncol. 7:184–203. 2015.PubMed/NCBI
|
|
2
|
Gustavsson B, Carlsson G, Machover D,
Petrelli N, Roth A, Schmoll HJ, Tveit KM and Gibson F: A review of
the evolution of systemic chemotherapy in the management of
colorectal cancer. Clin Colorectal Cancer. 14:1–10. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Banjerdpongchai R, Chanwikruy Y,
Rattanapanone V and Sripanidkulchai B: Induction of apoptosis in
the human leukemic U937 cell line by Kaempferia parviflora
Wall.ex.Baker extract and effects of paclitaxel and camptothecin.
Asian Pac J Cancer Prev. 10:1137–1140. 2009.PubMed/NCBI
|
|
4
|
Weaver BA: How Taxol/paclitaxel kills
cancer cells. Mol Biol Cell. 25:2677–2681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Owona BA and Schluesener HJ: Molecular
insight in the multifunctional effects of oridonin. Drugs R D.
15:233–244. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu Y, Liu YZ, Zhang RX, Wang X, Meng ZJ,
Huang J, Wu K, Luo JY, Zuo GW, Chen L, et al: Oridonin inhibits the
proliferation of human osteosarcoma cells by suppressing
Wnt/β-catenin signaling. Int J Oncol. 45:795–803. 2014.PubMed/NCBI
|
|
7
|
Voorneveld PW, Kodach LL, Jacobs RJ, Liv
N, Zonnevylle AC, Hoogenboom JP, Biemond I, Verspaget HW, Hommes
DW, de Rooij K, et al: Loss of SMAD4 alters BMP signaling to
promote colorectal cancer cell metastasis via activation of Rho and
ROCK. Gastroenterology. 147:196–208.e13. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bertrand FE, Angus CW, Partis WJ and
Sigounas G: Developmental pathways in colon cancer: Crosstalk
between WNT, BMP, Hedgehog and Notch. Cell Cycle. 11:4344–4351.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Beck SE, Jung BH, Fiorino A, Gomez J,
Rosario ED, Cabrera BL, Huang SC, Chow JY and Carethers JM: Bone
morphogenetic protein signaling and growth suppression in colon
cancer. Am J Physiol Gastrointest Liver Physiol. 291:G135–G145.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y, Chen X, Qiao M, Zhang BQ, Wang N,
Zhang Z, Liao Z, Zeng L, Deng Y, Deng F, et al: Bone morphogenetic
protein 2 inhibits the proliferation and growth of human colorectal
cancer cells. Oncol Rep. 32:1013–1020. 2014.PubMed/NCBI
|
|
11
|
Lombardo Y, Scopelliti A, Cammareri P,
Todaro M, Iovino F, Ricci-Vitiani L, Gulotta G, Dieli F, de Maria R
and Stassi G: Bone morphogenetic protein 4 induces differentiation
of colorectal cancer stem cells and increases their response to
chemotherapy in mice. Gastroenterology. 140:297–309. 2011.
View Article : Google Scholar
|
|
12
|
Kamiya N, Ye L, Kobayashi T, Lucas DJ,
Mochida Y, Yamauchi M, Kronenberg HM, Feng JQ and Mishina Y:
Disruption of BMP signaling in osteoblasts through type IA receptor
(BMPRIA) increases bone mass. J Bone Miner Res. 23:2007–2017. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Richard D and Picard F: Brown fat biology
and thermogenesis. Front Biosci. 16:1233–1260. 2011. View Article : Google Scholar
|
|
14
|
Grijelmo C, Rodrigue C, Svrcek M, Bruyneel
E, Hendrix A, de Wever O and Gespach C: Proinvasive activity of
BMP-7 through SMAD4/src-independent and ERK/Rac/JNK-dependent
signaling pathways in colon cancer cells. Cell Signal.
19:1722–1732. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tormos AM, Taléns-Visconti R, Nebreda AR
and Sastre J: p38 MAPK: A dual role in hepatocyte proliferation
through reactive oxygen species. Free Radic Res. 47:905–916. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bu HQ, Liu DL, Wei WT, Chen L, Huang H, Li
Y and Cui JH: Oridonin induces apoptosis in SW1990 pancreatic
cancer cells via p53- and caspase-dependent induction of p38 MAPK.
Oncol Rep. 31:975–982. 2014.
|
|
17
|
Bu HQ, Luo J, Chen H, Zhang JH, Li HH, Guo
HC, Wang ZH and Lin SZ: Oridonin enhances antitumor activity of
gemcitabine in pancreatic cancer through MAPK-p38 signaling
pathway. Int J Oncol. 41:949–958. 2012.PubMed/NCBI
|
|
18
|
Guan J, Li H, Lv T, Chen D, Yuan Y and Qu
S: Bone morphogenic protein-7 contributes to cerebral ischemic
preconditioning induced-ischemic tolerance by activating p38
mitogen-activated protein kinase signaling pathway. Inflammation.
37:1289–1296. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Takahashi M, Otsuka F, Miyoshi T, Otani H,
Goto J, Yamashita M, Ogura T, Makino H and Doihara H: Bone
morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced
proliferation of breast cancer cells by suppressing p38
mitogen-activated protein kinase activation. J Endocrinol.
199:445–455. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Luo J, Deng ZL, Luo X, Tang N, Song WX,
Chen J, Sharff KA, Luu HH, Haydon RC, Kinzler KW, et al: A protocol
for rapid generation of recombinant adenoviruses using the AdEasy
system. Nat Protoc. 2:1236–1247. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mishra L, Shetty K, Tang Y, Stuart A and
Byers SW: The role of TGF-beta and Wnt signaling in
gastrointestinal stem cells and cancer. Oncogene. 24:5775–5789.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu YQ, Mu ZQ, You S, Tashiro S, Onodera S
and Ikejima T: Fas/FasL signaling allows extracelluar-signal
regulated kinase to regulate cytochrome c release in
oridonin-induced apoptotic U937 cells. Biol Pharm Bull.
29:1873–1879. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hsieh TC, Wijeratne EK, Liang JY,
Gunatilaka AL and Wu JM: Differential control of growth, cell cycle
progression, and expression of NF-κB in human breast cancer cells
MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin,
diterpenoids from the Chinese herb Rabdosia rubescens. Biochem
Biophys Res Commun. 337:224–231. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou GB, Kang H, Wang L, Gao L, Liu P, Xie
J, Zhang FX, Weng XQ, Shen ZX, Chen J, et al: Oridonin, a
diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion
protein and shows potent antitumor activity with low adverse
effects on t(8;21) leukemia in vitro and in vivo. Blood.
109:3441–3450. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu Y, Xie L, Chen G, Wang H and Zhang R:
Effects of oridonin on proliferation of HT29 human colon carcinoma
cell lines both in vitro and in vivo in mice. Pharmazie.
62:439–444. 2007.PubMed/NCBI
|
|
26
|
Li D, Wu LJ, Tashiro S, Onodera S and
Ikejima T: Oridonin-induced A431 cell apoptosis partially through
blockage of the Ras/Raf/ERK signal pathway. J Pharmacol Sci.
103:56–66. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hu HZ, Yang YB, Xu XD, Shen HW, Shu YM,
Ren Z, Li XM, Shen HM and Zeng HT: Oridonin induces apoptosis via
PI3K/Akt pathway in cervical carcinoma HeLa cell line. Acta
Pharmacol Sin. 28:1819–1826. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gao FH, Liu F, Wei W, Liu LB, Xu MH, Guo
ZY, Li W, Jiang B and Wu YL: Oridonin induces apoptosis and
senescence by increasing hydrogen peroxide and glutathione
depletion in colorectal cancer cells. Int J Mol Med. 29:649–655.
2012.PubMed/NCBI
|
|
29
|
Markowitz SD and Bertagnolli MM: Molecular
origins of cancer: Molecular basis of colorectal cancer. N Engl J
Med. 361:2449–2460. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Saini S, Duraisamy AJ, Bayen S, Vats P and
Singh SB: Role of BMP7 in appetite regulation, adipogenesis, and
energy expenditure. Endocrine. 48:405–409. 2015. View Article : Google Scholar
|
|
31
|
Kuzaka B, Janiak M, Włodarski KH,
Radziszewski P and Włodarski PK: Expression of bone morphogenetic
protein-2 and -7 in urinary bladder cancer predicts time to tumor
recurrence. Arch Med Sci. 11:378–384. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li W, Cai HX, Ge XM, Li K, Xu WD and Shi
WH: Prognostic significance of BMP7 as an oncogene in
hepatocellular carcinoma. Tumour Biol. 34:669–674. 2013. View Article : Google Scholar
|
|
33
|
Aoki M, Ishigami S, Uenosono Y, Arigami T,
Uchikado Y, Kita Y, Kurahara H, Matsumoto M, Ueno S and Natsugoe S:
Expression of BMP-7 in human gastric cancer and its clinical
significance. Br J Cancer. 104:714–718. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu Y, Chen J, Yang Y, Zhang L and Jiang
WG: Molecular impact of bone morphogenetic protein 7, on lung
cancer cells and its clinical significance. Int J Mol Med.
29:1016–1024. 2012.PubMed/NCBI
|
|
35
|
Alarmo EL, Pärssinen J, Ketolainen JM,
Savinainen K, Karhu R and Kallioniemi A: BMP7 influences
proliferation, migration, and invasion of breast cancer cells.
Cancer Lett. 275:35–43. 2009. View Article : Google Scholar
|
|
36
|
Ying X, Sun Y and He P: Bone morphogenetic
protein-7 inhibits EMT-associated genes in breast cancer. Cell
Physiol Biochem. 37:1271–1278. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lim M, Chuong CM and Roy-Burman P: PI3K,
Erk signaling in BMP7-induced epithelial-mesenchymal transition
(EMT) of PC-3 prostate cancer cells in 2- and 3-dimensional
cultures. Horm Cancer. 2:298–309. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Motoyama K, Tanaka F, Kosaka Y, Mimori K,
Uetake H, Inoue H, Sugihara K and Mori M: Clinical significance of
BMP7 in human colorectal cancer. Ann Surg Oncol. 15:1530–1537.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Camara-Clayette V, Koscielny S, Roux S,
Lamy T, Bosq J, Bernard M, Fest T, Lazar V, Lenoir G and Ribrag V:
BMP7 expression correlates with secondary drug resistance in mantle
cell lymphoma. PLoS One. 8:e739932013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fiaschetti G, Castelletti D, Zoller S,
Schramm A, Schroeder C, Nagaishi M, Stearns D, Mittelbronn M,
Eggert A, Westermann F, et al: Bone morphogenetic protein-7 is a
MYC target with prosur-vival functions in childhood
medulloblastoma. Oncogene. 30:2823–2835. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Itoh F, Asao H, Sugamura K, Heldin CH, ten
Dijke P and Itoh S: Promoting bone morphogenetic protein signaling
through negative regulation of inhibitory Smads. EMBO J.
20:4132–4142. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Greenblatt MB, Kim JM, Oh H, Park KH, Choo
MK, Sano Y, Tye CE, Skobe Z, Davis RJ, Park JM, et al: p38α MAPK is
required for tooth morphogenesis and enamel secretion. J Biol Chem.
290:284–295. 2015. View Article : Google Scholar :
|
